Social Wire
Posted
Aug 14, 2017
Been a busy summer here at Longevity Biotech. Check out this recent commentary in The Lancet regarding autoimmunity and Parkinson's Disease from our friends at University of Nebraska Medical Center - UNMC (17)30276-4/abstract
Bottom line is that there is still more work to be done, contact us for more information!
Posted
Apr 25, 2017
Looking for a new exciting, challenging job where you have an impact? Well, we are hiring...
Posted
Mar 24, 2017
Congrats to the University of Nebraska Medical Center - UNMC team. We look forward to continuing our collaboration and developing the next generation drug candidates.
Posted
Mar 23, 2017
Huge congrats to our friends at University of Nebraska Medical Center - UNMC on the publication of their Parkinson's disease clinical trial! Exciting times indeed!
Posted
Feb 13, 2017
Longevity Biotech is pleased to be included as one of the emerging new classes of therapeutics for the most challenging drug targets. Contact us for more information on how Hybridtides© can help your therapeutics program...
Posted
Feb 7, 2017
We are pleased to share the press release that went out this morning about our Parkinson's disease program and our collaborations with University of Nebraska Medical Center - UNMC and The Michael J. Fox Foundation for Parkinson's Research. Great work team!
Posted
Dec 28, 2016
Longevity Biotech will be attending the upcoming #RESI17 conference on Tuesday Jan 10th 2017. We still have a few meeting times available during #JPM17 week - please contact us to learn more about our neuroscience & diabetes programs and how we are attempting to treat these diseases by targeting gut receptors with our Hybridtide platform technology!
Posted
Dec 28, 2016
Longevity Biotech attended the FasterCures event in NYC () earlier this month and met with some outstanding and like-minded partners / investors.
Posted
Oct 19, 2016
Michael J. Fox Foundation Parkinson's Disease Therapeutics Conference